Literature DB >> 3356151

Sample size for comparison of changes in the presence of right censoring caused by death, withdrawal, and staggered entry.

M C Wu1.   

Abstract

In estimating and comparing the rates of change of a continuous variable between two groups, the unweighted averages of individual simple least-square estimates from each group are often used. Under the linear random effects model, these statistics are maximum likelihood estimates for the expected rates of change when all individuals have complete observations. However, death and withdrawal often cause observations on the variable of interest to be right censored for some participants, which makes any subsequent measurements impossible (to be referred to as right censoring). In this situation, the unweighted averages are no longer efficient in comparison with the generalized least-square estimates. Relationship between sample size, frequency of measurement, and right censoring are described for the different estimation procedures. Using realistic estimates of the random effect parameters, we illustrate that if there were 8% right censored observations each year due to participants' death or loss to follow-up, the sample size requirements for a proposed 3-year controlled clinical trial of alpha 1-protease inhibitor replacement therapy could be more than doubled if the unweighed rather than the generalized least-square estimates were used.

Entities:  

Mesh:

Year:  1988        PMID: 3356151     DOI: 10.1016/0197-2456(88)90007-4

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  8 in total

1.  Slope Estimation of Covariates that Influence Renal Outcome following Renal Transplant Adjusting for Informative Right Censoring.

Authors:  Miran A Jaffa; Ayad A Jaffa; Stuart R Lipsitz
Journal:  J Appl Stat       Date:  2012       Impact factor: 1.404

2.  Rule-of-thumb adjustment of sample sizes to accommodate dropouts in a two-stage analysis of repeated measurements.

Authors:  John E Overall; Scott Tonidandel; Robert R Starbuck
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

3.  Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data.

Authors:  Mark D Schluchter; Michael W Konstan; Mitchell L Drumm; James R Yankaskas; Michael R Knowles
Journal:  Am J Respir Crit Care Med       Date:  2006-07-20       Impact factor: 21.405

4.  A comparison of power analysis methods for evaluating effects of a predictor on slopes in longitudinal designs with missing data.

Authors:  Cuiling Wang; Charles B Hall; Mimi Kim
Journal:  Stat Methods Med Res       Date:  2012-02-21       Impact factor: 3.021

5.  Power and sample size calculations for evaluating mediation effects in longitudinal studies.

Authors:  Cuiling Wang; Xiaonan Xue
Journal:  Stat Methods Med Res       Date:  2012-12-06       Impact factor: 3.021

6.  Disease severity and progression in progressive supranuclear palsy and multiple system atrophy: validation of the NNIPPS--Parkinson Plus Scale.

Authors:  Christine A M Payan; François Viallet; Bernhard G Landwehrmeyer; Anne-Marie Bonnet; Michel Borg; Franck Durif; Lucette Lacomblez; Frédéric Bloch; Marc Verny; Jacques Fermanian; Yves Agid; Albert C Ludolph; Peter N Leigh; Gilbert Bensimon
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

Review 7.  Sample sizes in dosage investigational clinical trials: a systematic evaluation.

Authors:  Ji-Han Huang; Qian-Min Su; Juan Yang; Ying-Hua Lv; Ying-Chun He; Jun-Chao Chen; Ling Xu; Kun Wang; Qing-Shan Zheng
Journal:  Drug Des Devel Ther       Date:  2015-01-07       Impact factor: 4.162

8.  Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.

Authors:  Gilbert Bensimon; Albert Ludolph; Yves Agid; Marie Vidailhet; Christine Payan; P Nigel Leigh
Journal:  Brain       Date:  2008-11-23       Impact factor: 13.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.